Archive

August 26, 2020

New Version of Bumetanide May Treat Autism While Reducing Side Effects

talian researchers report that a new small molecule they developed has reduced autism brain pathology in a mouse model of autism. The compound was also effective in reducing the core autism-like social and repetitive behaviors in the valproic acid (VPA) mouse model of ASD.

Show Buttons
Hide Buttons